The pharma CEO, now hit with securities fraud charges, is a potent symbol of corporate greed. Now we need to learn from Shkreli's bad example and reform his industry, writes Kit Williamson.
The pharmaceutical CEO, who recently hiked the cost of an AIDS drug, had hoped to parlay his contribution into a private meeting with the presidential candidate.
The accused stock swindler who famously jacked up the price of a lifesaving drug 5,000 percent will finally face a judge, on the very day LGBT people celebrate marriage equality.
Derided for raising the price of a medication used by some with HIV, the former drug executive refused to answer questions and later insulted the committee.
A report says Martin Shkreli's Turing Pharmaceuticals will 'roll back' the price of a lifesaving treatment for people living with HIV — but only for hospitals.
